T2D Excellence Forum

Excellence Forum

Leaders in the field share expert insights and institutional best practices.

Q&As

Expert Q&A
Dr Tang
Expert Q&A
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Expert Q&A
12/09/2023
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
12/09/2023
Expert Q&A
Expert Q&A
11/30/2023

Robin Gal, MSPH, CCRA • Grazia Aleppo, MD, FACE, FACP •  Teresa McArthur, MS, RD, CDCES

Robin Gal, MSPH, CCRA • Gra...
In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...
11/30/2023